TITLE

Celebrex sets $25 mil blitz despite FDA snag

AUTHOR(S)
Goetzl, David; Ross, Chuck; Snyder, Beth
PUB. DATE
May 1999
SOURCE
Advertising Age;5/3/1999, Vol. 70 Issue 19, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Looks at the marketing of Celebrex, an anti-arthritis drug from Monsanto Co. and Pfizer. How the drug will be advertised in a direct-to-consumer pharmaceutical television advertising campaign; Negotiations between Monsanto and the United States Food and Drug Administration about the drug's name; Options for the drug marketers in using unbranded advertising; Celebrex being in the category of drugs known as Cox-2 inhibitors.
ACCESSION #
1827358

 

Share

Read the Article

Courtesy of MICHIGAN ELIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics